ml297  (Alomone Labs)


Bioz Verified Symbol Alomone Labs is a verified supplier
Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Alomone Labs ml297
    Rescue of GIRK channel activity by VU0529331 and <t>ML297</t> in the presence of LoF mutants I80N and I80T Oocytes expressed GIRK2 (2 ng RNA) or GIRK1/3 (3 ng) channels, with or without Gβ WT (5 ng), I80N and I80T (10 ng), and Gγ (1/5 of Gβ). (A) Representative records of GIRK2 currents and their activation by 40 μM of VU0529331 in oocytes expressing Gβγ. (B and C) Summary of GIRK2 currents with and without Gβγ before (B) and after (C) the application of 40 μM VU0529331. (D) Fold activation of GIRK2 by 40 μM of VU0529331. (E) GIRK1/3 currents and their activation by 10 μM of ML297 in the presence of Gβγ. (F and G) Summary of GIRK1/3 currents with and without Gβγ before (F) and after (G) the application of 10 μM ML297. (H) Fold activation of GIRK1/3 by 10 μM of ML297 (N = 1).
    Ml297, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ml297/product/Alomone Labs
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ml297 - by Bioz Stars, 2022-07
    93/100 stars

    Images

    1) Product Images from "Encephalopathy-causing mutations in Gβ1 (GNB1) alter regulation of neuronal GIRK channels"

    Article Title: Encephalopathy-causing mutations in Gβ1 (GNB1) alter regulation of neuronal GIRK channels

    Journal: iScience

    doi: 10.1016/j.isci.2021.103018

    Rescue of GIRK channel activity by VU0529331 and ML297 in the presence of LoF mutants I80N and I80T Oocytes expressed GIRK2 (2 ng RNA) or GIRK1/3 (3 ng) channels, with or without Gβ WT (5 ng), I80N and I80T (10 ng), and Gγ (1/5 of Gβ). (A) Representative records of GIRK2 currents and their activation by 40 μM of VU0529331 in oocytes expressing Gβγ. (B and C) Summary of GIRK2 currents with and without Gβγ before (B) and after (C) the application of 40 μM VU0529331. (D) Fold activation of GIRK2 by 40 μM of VU0529331. (E) GIRK1/3 currents and their activation by 10 μM of ML297 in the presence of Gβγ. (F and G) Summary of GIRK1/3 currents with and without Gβγ before (F) and after (G) the application of 10 μM ML297. (H) Fold activation of GIRK1/3 by 10 μM of ML297 (N = 1).
    Figure Legend Snippet: Rescue of GIRK channel activity by VU0529331 and ML297 in the presence of LoF mutants I80N and I80T Oocytes expressed GIRK2 (2 ng RNA) or GIRK1/3 (3 ng) channels, with or without Gβ WT (5 ng), I80N and I80T (10 ng), and Gγ (1/5 of Gβ). (A) Representative records of GIRK2 currents and their activation by 40 μM of VU0529331 in oocytes expressing Gβγ. (B and C) Summary of GIRK2 currents with and without Gβγ before (B) and after (C) the application of 40 μM VU0529331. (D) Fold activation of GIRK2 by 40 μM of VU0529331. (E) GIRK1/3 currents and their activation by 10 μM of ML297 in the presence of Gβγ. (F and G) Summary of GIRK1/3 currents with and without Gβγ before (F) and after (G) the application of 10 μM ML297. (H) Fold activation of GIRK1/3 by 10 μM of ML297 (N = 1).

    Techniques Used: Activity Assay, Activation Assay, Expressing

    2) Product Images from "Encephalopathy-causing mutations in Gβ1 (GNB1) alter regulation of neuronal GIRK channels"

    Article Title: Encephalopathy-causing mutations in Gβ1 (GNB1) alter regulation of neuronal GIRK channels

    Journal: iScience

    doi: 10.1016/j.isci.2021.103018

    Rescue of GIRK channel activity by VU0529331 and ML297 in the presence of LoF mutants I80N and I80T Oocytes expressed GIRK2 (2 ng RNA) or GIRK1/3 (3 ng) channels, with or without Gβ WT (5 ng), I80N and I80T (10 ng), and Gγ (1/5 of Gβ). (A) Representative records of GIRK2 currents and their activation by 40 μM of VU0529331 in oocytes expressing Gβγ. (B and C) Summary of GIRK2 currents with and without Gβγ before (B) and after (C) the application of 40 μM VU0529331. (D) Fold activation of GIRK2 by 40 μM of VU0529331. (E) GIRK1/3 currents and their activation by 10 μM of ML297 in the presence of Gβγ. (F and G) Summary of GIRK1/3 currents with and without Gβγ before (F) and after (G) the application of 10 μM ML297. (H) Fold activation of GIRK1/3 by 10 μM of ML297 (N = 1).
    Figure Legend Snippet: Rescue of GIRK channel activity by VU0529331 and ML297 in the presence of LoF mutants I80N and I80T Oocytes expressed GIRK2 (2 ng RNA) or GIRK1/3 (3 ng) channels, with or without Gβ WT (5 ng), I80N and I80T (10 ng), and Gγ (1/5 of Gβ). (A) Representative records of GIRK2 currents and their activation by 40 μM of VU0529331 in oocytes expressing Gβγ. (B and C) Summary of GIRK2 currents with and without Gβγ before (B) and after (C) the application of 40 μM VU0529331. (D) Fold activation of GIRK2 by 40 μM of VU0529331. (E) GIRK1/3 currents and their activation by 10 μM of ML297 in the presence of Gβγ. (F and G) Summary of GIRK1/3 currents with and without Gβγ before (F) and after (G) the application of 10 μM ML297. (H) Fold activation of GIRK1/3 by 10 μM of ML297 (N = 1).

    Techniques Used: Activity Assay, Activation Assay, Expressing

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93
    Alomone Labs ml297
    Rescue of GIRK channel activity by VU0529331 and <t>ML297</t> in the presence of LoF mutants I80N and I80T Oocytes expressed GIRK2 (2 ng RNA) or GIRK1/3 (3 ng) channels, with or without Gβ WT (5 ng), I80N and I80T (10 ng), and Gγ (1/5 of Gβ). (A) Representative records of GIRK2 currents and their activation by 40 μM of VU0529331 in oocytes expressing Gβγ. (B and C) Summary of GIRK2 currents with and without Gβγ before (B) and after (C) the application of 40 μM VU0529331. (D) Fold activation of GIRK2 by 40 μM of VU0529331. (E) GIRK1/3 currents and their activation by 10 μM of ML297 in the presence of Gβγ. (F and G) Summary of GIRK1/3 currents with and without Gβγ before (F) and after (G) the application of 10 μM ML297. (H) Fold activation of GIRK1/3 by 10 μM of ML297 (N = 1).
    Ml297, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ml297/product/Alomone Labs
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ml297 - by Bioz Stars, 2022-07
    93/100 stars
      Buy from Supplier

    93
    Alomone Labs gabazine
    GlyR α 4 receptors in SACs mediate slow and delayed sIPSCs. A. sIPSCs measured from ON SACs in wild-type mice at 0 mV in control ( left panel ). Normalized average fast (blue) and slow (red) sIPSCs ( middle panel ). Frequency distribution of rise, decay time and amplitude of the population events ( right panels ; n = 5 SACs). B-C . Same as A, but in <t>gabazine</t> (B) and strychnine (C) in wild-type SACs. D. same as A B except SAC recordings were made in Glra4 KO retina.
    Gabazine, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gabazine/product/Alomone Labs
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    gabazine - by Bioz Stars, 2022-07
    93/100 stars
      Buy from Supplier

    Image Search Results


    Rescue of GIRK channel activity by VU0529331 and ML297 in the presence of LoF mutants I80N and I80T Oocytes expressed GIRK2 (2 ng RNA) or GIRK1/3 (3 ng) channels, with or without Gβ WT (5 ng), I80N and I80T (10 ng), and Gγ (1/5 of Gβ). (A) Representative records of GIRK2 currents and their activation by 40 μM of VU0529331 in oocytes expressing Gβγ. (B and C) Summary of GIRK2 currents with and without Gβγ before (B) and after (C) the application of 40 μM VU0529331. (D) Fold activation of GIRK2 by 40 μM of VU0529331. (E) GIRK1/3 currents and their activation by 10 μM of ML297 in the presence of Gβγ. (F and G) Summary of GIRK1/3 currents with and without Gβγ before (F) and after (G) the application of 10 μM ML297. (H) Fold activation of GIRK1/3 by 10 μM of ML297 (N = 1).

    Journal: iScience

    Article Title: Encephalopathy-causing mutations in Gβ1 (GNB1) alter regulation of neuronal GIRK channels

    doi: 10.1016/j.isci.2021.103018

    Figure Lengend Snippet: Rescue of GIRK channel activity by VU0529331 and ML297 in the presence of LoF mutants I80N and I80T Oocytes expressed GIRK2 (2 ng RNA) or GIRK1/3 (3 ng) channels, with or without Gβ WT (5 ng), I80N and I80T (10 ng), and Gγ (1/5 of Gβ). (A) Representative records of GIRK2 currents and their activation by 40 μM of VU0529331 in oocytes expressing Gβγ. (B and C) Summary of GIRK2 currents with and without Gβγ before (B) and after (C) the application of 40 μM VU0529331. (D) Fold activation of GIRK2 by 40 μM of VU0529331. (E) GIRK1/3 currents and their activation by 10 μM of ML297 in the presence of Gβγ. (F and G) Summary of GIRK1/3 currents with and without Gβγ before (F) and after (G) the application of 10 μM ML297. (H) Fold activation of GIRK1/3 by 10 μM of ML297 (N = 1).

    Article Snippet: ML297 (Alomone Labs; M-215) was dissolved in 100% DMSO to a final concentration of 25 mM.

    Techniques: Activity Assay, Activation Assay, Expressing

    GlyR α 4 receptors in SACs mediate slow and delayed sIPSCs. A. sIPSCs measured from ON SACs in wild-type mice at 0 mV in control ( left panel ). Normalized average fast (blue) and slow (red) sIPSCs ( middle panel ). Frequency distribution of rise, decay time and amplitude of the population events ( right panels ; n = 5 SACs). B-C . Same as A, but in gabazine (B) and strychnine (C) in wild-type SACs. D. same as A B except SAC recordings were made in Glra4 KO retina.

    Journal: bioRxiv

    Article Title: Gain control by sparse, ultra-slow glycinergic synapses

    doi: 10.1101/2021.05.03.442480

    Figure Lengend Snippet: GlyR α 4 receptors in SACs mediate slow and delayed sIPSCs. A. sIPSCs measured from ON SACs in wild-type mice at 0 mV in control ( left panel ). Normalized average fast (blue) and slow (red) sIPSCs ( middle panel ). Frequency distribution of rise, decay time and amplitude of the population events ( right panels ; n = 5 SACs). B-C . Same as A, but in gabazine (B) and strychnine (C) in wild-type SACs. D. same as A B except SAC recordings were made in Glra4 KO retina.

    Article Snippet: TTX and gabazine were purchased from Alamone Labs and Tocris, respectively.

    Techniques: Mouse Assay

    Glycine, not GABA receptors, mediate the dominant form of inhibition to SACs. A. IPSCs recorded from an ON SAC (at ∼0mV) evoked by small stationary spots (2 s;100 μm diameter) in control (black), in the presence of GlyR antagonist (1 µM strychnine, red) and following addition of the GABA A R antagonist, gabazine (grey). Inset shows the transient response in the boxed region at higher magnification. B. Average ON ( top and middle ) and OFF ( bottom ) inhibitory responses measured across 6 cells (black-mean ± SEM, grey-individual cells) in three conditions as shown in A. The middle panel plots the same data as the top panel and is magnified to highlight the significant reduction of ON inhibitory charge in gabazine. (* p

    Journal: bioRxiv

    Article Title: Gain control by sparse, ultra-slow glycinergic synapses

    doi: 10.1101/2021.05.03.442480

    Figure Lengend Snippet: Glycine, not GABA receptors, mediate the dominant form of inhibition to SACs. A. IPSCs recorded from an ON SAC (at ∼0mV) evoked by small stationary spots (2 s;100 μm diameter) in control (black), in the presence of GlyR antagonist (1 µM strychnine, red) and following addition of the GABA A R antagonist, gabazine (grey). Inset shows the transient response in the boxed region at higher magnification. B. Average ON ( top and middle ) and OFF ( bottom ) inhibitory responses measured across 6 cells (black-mean ± SEM, grey-individual cells) in three conditions as shown in A. The middle panel plots the same data as the top panel and is magnified to highlight the significant reduction of ON inhibitory charge in gabazine. (* p

    Article Snippet: TTX and gabazine were purchased from Alamone Labs and Tocris, respectively.

    Techniques: Inhibition